Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas

Virchows Archiv

Volumn 431, Issue 5, 1997, Pages 317-321

  Bukholm, Ida K ^a   Nesland, Jahn M ^b   Kåresen, Rolf ^c   Jacobsen, Ulf ^d   Børresen Dale, Anne Lise ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d Buskerud Central Hospital   (Norway)

Author keywords

Breast carcinomas; E cadherin; Genomic instability; Immunohistochemistry; p53; TP53 gene

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53; UVOMORULIN;

ADULT; AGED; ALLELE; ARTICLE; BREAST CARCINOMA; DOWN REGULATION; FEMALE; GENE MUTATION; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030713979     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050105     Document Type: Article

References (23)

1. Albelda SM (1993) Role of integrins and other cell adhesion molecules in tumor progression and metastasis (review), Lab Invest 68: 4-17
2. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Borresen AL (1993) Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer 68: 540-548
3. Beahr OH, Henson DE, Hutter RVP, Myers MH (1988) Anonymous manual for staging of cancer, 3rd edn. Lippincott, Philadelphia
4. Bergerheim US, Kunimi K, Collins VP, Ekman P (1991) Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosom Cancer 3: 215-220
5. Berx G, Cleton-Jansen AM, Nollet F, Leeuw WJ de, Vijver M van de, Cornelisse C, Roy F van (1995) E-Cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancer. EMBO J 14: 6107-6115
6. Bukholm I, Nesland JM, Kåresen R, Jacobsen U, Borresen AL (1997) Relationship between abnormal p53 protein and failure to express p21. J Pathol (Lond) 181: 140-145
7. Chen WC, Obrink B (1991) Cell-cell contacts mediated by Ecadherin (uvomorulin) restrict invasive behavior of L-cells. J Cell Biol 114: 319-327
8. Doki Y, Shiozaki H, Tahara H, Inoue M, Oka H, lihara K, Kadowaki T, Takeichi M, Mori T (1993) Correlation between Ecadherin expression and invasiveness in vitro in a human esophageal cancer cell line. Cancer Res 53: 3421-3426
9. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
10. Eyfjord JE, Thorlacius S, Steinarsdottir M, Valgardsdottir R, Ogmundsdottir HM, Anamthawat-Jonssen K (1995) p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res 55: 646-651
11. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185
12. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A (1993) Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142: 987-993
13. Hsu SM, Raine L, Fanger H (1981) A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75: 734-738
14. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, lihara K, Matsui S, Iwazawa T, Nagafuchi A, et al (1994) E-Cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res 54: 291-296
15. Lindblom A, Rotstein S, Skoog L, Nordenskjold M, Larsson C (1993) Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. Cancer Res 53: 3707-3711
16. Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjanen K (1994) Expression of E-cadherin (E-CD) as related to otherprognostic factors and survival in breast cancer. J Pathol (Lond) 174: 101-109
17. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M, et al (1993) Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701
18. IS. Palacios J, Benito N, Pizarro A, Suarez A, Espada J, Cano A, Gamallo C (1995) Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol 146: 605-612
19. Pierceall WE, Woodard AS, Morrow JS, Rimm DL, Fearon ER (1995) Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Oncogene 11: 1319-1326
20. Rimm DL, Sinard JH, Morrow JS (1995) Reduced alpha-catenin and E-cadherin expression in breast cancer (see comments). Lab Invest 72: 506-512
21. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kusumi F, Sakamoto G, Nakamura Y (1990) Allelotype of breast cancer: cumultive allele losses promote tumor progression in primary breast cancer. Cancer Res 50: 7184-7189
22. Smith ML, Fornace AJ Jr (1995) Genomic instability and the role of p53 mutations in cancer cells (review). Curr Opin Oncol 7: 69-75
23. Vleminckx K, Vakaet L Jr, Marcel M, Fiers W, Roy F van (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119